2020 American Transplant Congress

May 30-June 1, 2020

ATC Virtual Congress
Live Broadcast Dates: May 30 - June 1, 2020
OnDemand Access: May 30, 2020 - June 4, 2021

Originally scheduled to take place in Philadelphia, this became a Virtual Congress due to COVID-19. For more information, visit The Official ATC Congress site.

View by Title View Sessions

View by Date

Saturday, May 30, 2020

3:30pm-4:00pm: Ureteral Complications Post Kidney Transplantation – Incidence and Preferred Treatment Modality

R. Patten¹, H. Mustafa², S. Desai³, J. Buggs⁴, E. Rogers⁴, A. Kumar¹, V. Bowers⁴

Poster Session C: Kidney Technical • Virtual

3:30pm-4:00pm: Urinary APOA4 as a Biomarker for Chronic Renal Allograft Injury and Rapid Renal Function Decline in Kidney Transplant Recipients

H. Jeon¹, D. Shin¹, J. Oh¹, J. Park², K. Ko³, J. Kim³, S. Lee³

Poster Session D: Biomarkers, Immune Assessment and Clinical Outcomes • Virtual

3:30pm-4:00pm: Urinary CXCL10: From Diagnosis to Prediction of BK Viremia in Kidney Transplantation

C. Tinel¹, A. Vermorel¹, D. Picciotto¹, L. Morin¹, C. Legendre¹, M. Rabant², D. Anglicheau¹

Poster Session A: Biomarkers, Immune Assessment and Clinical Outcomes • Virtual

3:30pm-4:00pm: Urinary Exosomal Hemopexin, a Validated Diagnostic Marker for Rejection in Kidney Transplant Recipients

J. Lee¹, J. Kim², G. Lee², S. Jeon², H. Noh², J. Lim², H. Jung², J. Choi², J. Cho², S. Park², Y. Kim², C. Kim²

Poster Session A: Biomarkers, Immune Assessment and Clinical Outcomes • Virtual

3:30pm-4:00pm: Urine Donor Derived Cell Free DNA Aids in the Diagnosis of BK Polyomavirus Nephropathy in Kidney Transplant Recipients with BK Viruria

G. Huang¹, X. Chen¹, W. Chen¹, P. Chen¹, T. Jiang², C. Wang¹, L. Chen¹

Poster Session C: Biomarkers, Immune Assessment and Clinical Outcomes • Virtual

3:30pm-4:00pm: Use of 16S Sequencing to Reveal Potential Respiratory Pathogens in Lung Transplant Recipients

C. Eskind¹, M. Shilts¹, H. Boone¹, J. Schmitz², C. Shaver³, S. Das¹, G. Satyanarayana¹

Poster Session B: All Infections (Excluding Kidney & Viral Hepatitis) • Virtual

3:30pm-4:00pm: Use of Angiotensin Converting Enzyme Inhibitors and Angiotensin II Receptor Blockers Therapy Prior to Kidney Transplantation Does Not Impact Recovery of Function

G. R. Bohan¹, J. Trofe-Clark¹, T. Fallah¹, M. Norris¹, R. D. Bloom², D. Sawinski², G. Malat¹

Poster Session C: Kidney Complications: Non-Immune Mediated Late Graft Failure • Virtual

3:30pm-4:00pm: Use of Cell Saver Leads to Lower Consumption of Blood Products During Liver Transplantation

R. Danc

Poster Session B: Liver: Hepatobiliary Surgery • Virtual

3:30pm-4:00pm: Use of Direct Acting Antiviral Medications in Transplant Recipients Receiving Organs from Hepatitis C Viremic Donors

S. Bova¹, A. Cameron¹, C. Durand¹, J. Katzianer², M. LeGrand², L. Boyer¹, J. Glorioso³, L. P. Toman¹

Poster Session D: Non-Organ Specific: Viral Hepatitis • Virtual

3:30pm-4:00pm: Use of Donor-Derived Cell-Free DNA Assay to Monitor Treatment Response to Allograft Rejection in Pediatric Renal Transplant Recipients

J. Steggerda¹, H. Phan Pizzo², J. Garrison², X. Zhang³, M. Haas⁴, I. Kim¹, S. Jordan¹, D. Puliyanda²

Poster Session B: Biomarkers, Immune Assessment and Clinical Outcomes • Virtual